Drug prices
Finally! Humira’s biosimilars also hit the us market!
Humira was first marketed in 2002 and was protected in the US market until 2023, thanks to AbbVie’s use of two strategies :
Andre Wencker
September 21, 2023
Dr. Bricker has made a name for himself in the US healthcare industry with his daily videos. In a few minutes, he presents the behind-the-scenes of different industry actors. He explains why certain mechanisms produce perverse effects, unfavorable to patients, drawing attention to unfair competition practices.
Bricker also gives advice on how to make the best use of the complicated American health care system!
All of that in short, clear and passionate video clips.
Today’s example discussed the complexity of the information contained in pharmacy prescriptions.
As always, Dr. Bricker points at the many opportunities for mistakes leading to this surprising statistic: 1 in 5 prescriptions includes errors!
With his permission we thought it useful to share this video on our website. Click here to access all of Dr Bricker’s videos available on Youtube. Enjoy!
As a reminder, patients who use Care2care’s international program through our partner pharmacies benefit from a verification of their prescription by a local doctor!
A comforting bonus for those who have listened to Dr. Bricker’s warning.
Humira was first marketed in 2002 and was protected in the US market until 2023, thanks to AbbVie’s use of two strategies :
After wrapping up the 2023 enrollment, employers are now planning their next moves to mitigate the continuously growing healthcare costs impacting their plans. This is particularly true for pharmacy costs.
PhRMA, a Big Pharma lobbying group, released an advertising touting that drug prices were not fueling inflation. To prove it, they produce the graphic below.
Care2Care secured a strategic partnership with an innovative, transparent, 100% pass-through PBM.
Adding to our expertise in international drug sourcing, we expand our offer to the full pharmacy benefit management.
